Detailed view for this entity.
Sorted into three lenses: who is speaking, what is being said about them, and where they are aligned or in conflict.
Claims about this entity's actions, status, or capabilities.
Subject
Quote from Video
Novo is down today another 5.7% after being down 15% or so the day before when the earnings got released too early.
“Novo is down today another 5.7% after being down 15% or so the day before when the earnings got released too early.”
Subject
Quote from Video
This outlook reflects a positive impact from a $4.2 billion reversal of sale rebate provision related to the 340B drug pricing program in the United States.
“This outlook reflects a positive impact from a $4.2 billion reversal of sale rebate provision related to the 340B drug pricing program in the United States.”
Subject
Quote from Video
And so you can start to understand why the stock took a big hit.
“And so you can start to understand why the stock took a big hit.”
Subject
Quote from Video
Novo is back to almost yet the bottom prices that we've seen at the end of 2025. Now of course if you thought that you missed it...
“Novo is back to almost yet the bottom prices that we've seen at the end of 2025. Now of course if you thought that you missed it...”